Drug intelligence / Profile preview

Kneipp Arnika Salbe S

Development stage
Unknown
Lead developer
Kneipp
Modality
Small Molecules
Administration
Topical
01

Overview

Kneipp Arnika Salbe S is a topical herbal medicinal product (phytomedicine) developed and marketed by Kneipp GmbH. The active ingredient is an oily extract derived from *Arnica montana* flowers, standardized at 10 g per 100 g of cream and extracted using refined sunflower oil. It is indicated for the external treatment of blunt traumatic injuries and their consequences, including bruising (hematomas), sprains, contusions, and fracture edema, as well as rheumatic muscle and joint complaints and inflammation resulting from insect bites. The therapeutic efficacy of the product is attributed to the anti-inflammatory and analgesic properties of arnica constituents, particularly sesquiterpene lactones such as helenalin. Kneipp Arnika Salbe S has been evaluated in Phase 4 randomized clinical trials comparing its safety and efficacy to topical ibuprofen (Ibutop Creme) for acute blunt impact sports injuries.

Brand names
Kneipp Arnika Salbe S
Other names
ArnikablütenauszugArnica montana flower extract
02

Targets

NF-κB

Beyond the preview

Go deeper on Kneipp Arnika Salbe S.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Kneipp Arnika Salbe S.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call